Promega Corporation

Capitalizing on China-Based Research and Development

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

Here we profile the Guangzhou Institute of Biomedicine and Health (GIBH), which was created to improve public health by promoting technology-driven innovation and international collaboration in biomedical research. GIBH is designed to be a “translational highway from bench to clinic”, focusing on the early stages of pharmaceutical discovery and development and partnering with other entities to bring lab discoveries to the clinic.  

Cell Notes 16, 20–21.

Michele Arduengo

Promega Corporation
Publication Date: 2006

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.